Smartphone assessments for diagnosing autism

Smartphone-Based Neurobehavioral Assessments as a Diagnostic Aid in Autism

Not applicable Interventional Blinklab Limited · NCT06497218

This study is testing a smartphone app that checks for signs of autism in children to see if it can accurately match up with traditional diagnoses.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment450 (estimated)
Ages3 Years to 12 Years
SexAll
SponsorBlinklab Limited Industry-sponsored
Locations1 site (Salé)
Trial IDNCT06497218 on ClinicalTrials.gov

What this trial studies

This study evaluates the diagnostic accuracy of a smartphone-based platform designed to conduct neurobehavioral assessments for Autism Spectrum Disorder (ASD). It is a retrospective multi-centre case-control study that compares the results of smartphone assessments with formal clinical diagnoses. The assessments involve measuring facial and behavioral reflexes through various neurometric tests while children watch an audio-normalized movie. The study aims to utilize machine learning algorithms to analyze the data collected from children diagnosed with ASD and neurotypical children.

Who should consider this trial

Good fit: Ideal candidates are children aged 3 to 12 years with a formal diagnosis of Autism Spectrum Disorder or neurotypical children without psychiatric diagnoses.

Not a fit: Patients outside the age range of 3 to 12 years or those with severe hearing or visual impairments may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could provide a more accessible and accurate method for diagnosing autism in children.

How similar studies have performed: While similar approaches using technology for diagnostic purposes have shown promise, this specific method is novel and has not been extensively tested.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female individuals between the ages of 3 - 12 years old at the time of consent.
* Caregiver must be able to read, understand and sign the Informed Consent Form (ICF).
* Normal or corrected-to-normal vision with visual acuity sufficient to watch short videos.
* Hearing adequate to hear the auditory stimuli delivered via headphones.

Exclusion Criteria:

* Participants under 3 or over 12 years old.
* Severe hearing or visual impairment.
* Participants using medication that affects the nervous system (classified as ATC N0 medication, https://www.whocc.no).

Where this trial is running

Salé

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Autism Spectrum Disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.